DK175837B1 - Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål - Google Patents

Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål Download PDF

Info

Publication number
DK175837B1
DK175837B1 DK198902031A DK203189A DK175837B1 DK 175837 B1 DK175837 B1 DK 175837B1 DK 198902031 A DK198902031 A DK 198902031A DK 203189 A DK203189 A DK 203189A DK 175837 B1 DK175837 B1 DK 175837B1
Authority
DK
Denmark
Prior art keywords
inhibitors
interleukin
inhs
processes
preparation
Prior art date
Application number
DK198902031A
Other languages
Danish (da)
English (en)
Other versions
DK203189A (da
DK203189D0 (da
Inventor
Jean-Michel Dayer
Philippe Lucien Seckinger
Gonzalo Jose Mazzei
Alan Reed Shaw
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22218720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK175837(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of DK203189A publication Critical patent/DK203189A/da
Publication of DK203189D0 publication Critical patent/DK203189D0/da
Priority to DK200100296A priority Critical patent/DK175969B1/da
Application granted granted Critical
Publication of DK175837B1 publication Critical patent/DK175837B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
DK198902031A 1987-08-26 1989-04-26 Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål DK175837B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200100296A DK175969B1 (da) 1987-08-26 2001-02-22 Fremgangsmåde til oprensning af interleukin 1 inhibitorer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8963287A 1987-08-26 1987-08-26
PCT/US1988/002819 WO1989001946A1 (fr) 1987-08-26 1988-08-17 Substances biologiques et procedes de production et d'utilisation de ces substances biologiques en therapeutique

Publications (3)

Publication Number Publication Date
DK203189A DK203189A (da) 1989-04-26
DK203189D0 DK203189D0 (da) 1989-04-26
DK175837B1 true DK175837B1 (da) 2005-03-21

Family

ID=22218720

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198902031A DK175837B1 (da) 1987-08-26 1989-04-26 Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål

Country Status (20)

Country Link
EP (1) EP0341273B1 (fr)
JP (2) JP3014099B2 (fr)
KR (2) KR0138919B1 (fr)
AT (1) ATE147408T1 (fr)
AU (1) AU633471B2 (fr)
BE (1) BE1002375A3 (fr)
CA (1) CA1341026C (fr)
DE (1) DE3855747T2 (fr)
DK (1) DK175837B1 (fr)
ES (3) ES2015348A6 (fr)
FR (1) FR2621821A1 (fr)
GB (1) GB2220662A (fr)
HK (1) HK1007748A1 (fr)
IL (1) IL87543A0 (fr)
IT (1) IT1226855B (fr)
NL (1) NL8820676A (fr)
NZ (1) NZ225940A (fr)
SE (1) SE8901342D0 (fr)
WO (1) WO1989001946A1 (fr)
ZA (1) ZA886251B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
BR8907457A (pt) * 1988-05-27 1991-04-02 Synergen Inc Inibidores de interleucina-1
CA2068320C (fr) * 1989-11-29 2000-10-17 Robert Hageman Production d'un inhibiteur recombinant de l'interleukine-1 humaine
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1991017184A1 (fr) * 1990-04-27 1991-11-14 The Upjohn Company Inhibiteurs ameliores d'interleukine-1
ATE178094T1 (de) * 1990-05-01 1999-04-15 Chiron Corp Interleukin-i antagonist und seine verwendung
NZ310561A (en) * 1995-09-13 1999-07-29 Takeda Chemical Industries Ltd Immunosuppressant of the aromatic variety based upon the quinoline family
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
GB8912533D0 (en) 1989-08-02
SE8901342L (sv) 1989-04-13
JPH02500643A (ja) 1990-03-08
ES2017275A6 (es) 1991-01-16
EP0341273B1 (fr) 1997-01-08
NL8820676A (nl) 1989-07-03
ES2017274A6 (es) 1991-01-16
DK203189A (da) 1989-04-26
ES2015348A6 (es) 1990-08-16
KR0138919B1 (ko) 1998-04-30
AU2427288A (en) 1989-03-31
IT1226855B (it) 1991-02-19
KR0138654B1 (ko) 1998-04-30
JPH10327862A (ja) 1998-12-15
WO1989001946A1 (fr) 1989-03-09
SE8901342D0 (sv) 1989-04-13
BE1002375A3 (fr) 1991-01-22
HK1007748A1 (en) 1999-04-23
ZA886251B (en) 1990-04-25
FR2621821A1 (fr) 1989-04-21
DE3855747D1 (de) 1997-02-20
IL87543A0 (en) 1989-01-31
KR890701629A (ko) 1989-12-21
NZ225940A (en) 1992-06-25
EP0341273A1 (fr) 1989-11-15
AU633471B2 (en) 1993-02-04
JP3217752B2 (ja) 2001-10-15
CA1341026C (fr) 2000-06-13
DK203189D0 (da) 1989-04-26
JP3014099B2 (ja) 2000-02-28
EP0341273A4 (en) 1990-09-19
DE3855747T2 (de) 1997-06-12
GB2220662A (en) 1990-01-17
ATE147408T1 (de) 1997-01-15
IT8821743A0 (it) 1988-08-25

Similar Documents

Publication Publication Date Title
ATE113295T1 (de) Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren.
MY101852A (en) Tumor necrosis factor, methods for its preparation, containing it, dna encoding it and assay method using such dna.
BR9408025A (pt) Compostos de peptidila e seu uso terapêutico como inibidores de metaloproteinases
DK175837B1 (da) Interleukin I inhibitorer, fremgangsmåder til fremstilling deraf samt deres anvendelse til terapeutiske formål
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
EA200001124A1 (ru) Способ генной терапии
DE60037978D1 (de) Interferon ähnliche moleküle, und deren verwendungen
NO972907L (no) 3,3-(Disubstituerte)cykloheksan-1-ol-monomerer og beslektede forbindelser

Legal Events

Date Code Title Description
PUP Patent expired